SKYE Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Skye Bioscience, Inc.

Skye Bioscience - logo grafis emiten SKYE

Analyzing the chart on GURU.Markets, we find that the current quarterly EPS rate demonstrates a trend where the value 100.40 serves as the baseline indicator. The operating model of Skye Bioscience, Inc. (SKYE) relies on contract outsourcing for production and marketing. This supports the development of SBI-100 with high pricing power for the treatment of glaucoma, while patent protection for obesity drugs creates barriers for competitors.

Wutah bathi EPS kuartalan skyebioscience.com (SKYE): kanggo periode 12.04.2024 - 16.11.2026

Rincian analitis perusahaan Skye Bioscience, Inc.

- nilai pasar lan prakiraan target analis:
Ringkesan analitik perusahaan:Skye Bioscience, Inc. - SKYE
Barang unggulan skyebioscience.com

The commercialization dynamics of glaucoma and obesity drugs directly determine the financial stability of Skye Bioscience, Inc. (SKYE). This indicator measures the percentage change in net earnings per share compared to the same period last year. By analyzing quarterly EPS growth, an investor identifies the gap between accounting reports and actual cash flow. A positive trend confirms the effectiveness of cannabinoid drug development, yet signals a risk of overvaluation. Conversely, a decline indicates a fundamental drawdown of capital.

Pesaing langsung

Indivior Corp (INDV) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan Collegium Pharmaceutical Inc|CRON (thecronosgroup.com) - Wutah bathi EPS kuartalan|Wutah bathi EPS kuartalan canopygrowth.com|Wutah bathi EPS kuartalan HITI|ACB (Aurora Cannabis, Inc.) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan ACHV (Achieve Life Sciences, Inc)|Anebulo (ANEB) - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Canndoc - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan NTRB (nutriband.com)|Nasus Pharma Ltd (NSRX) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|India Globalization Capital - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan MIRA Pharma|FLGC: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan IMC (IMCC)|ADIL: Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan ARTL (Artelo)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan ENSC|Titan Pharmaceuticals - Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Greenlane Holdings|inmedpharma.com (INM) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan AKAN|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Enveric Corp|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan brightgreen.us BGXX|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HPCO (Hempacco Co Inc.)